These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11512564)

  • 1. Concentration of nitric oxide (NO) in spinal fluid of chronic spinal disease.
    Yumite Y; Takeuchi K; Harada Y; Ogawa N; Inoue H
    Acta Med Okayama; 2001 Aug; 55(4):219-28. PubMed ID: 11512564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated concentration of hyaluronan in the cerebrospinal fluid is a secondary marker of spinal disorders: hyaluronan in the cerebrospinal fluid in patients with spinal disorders.
    Sakayama K; Kidani T; Sugawara Y; Masuno H; Matsuda Y; Yamamoto H
    J Spinal Disord Tech; 2006 Jun; 19(4):262-5. PubMed ID: 16778660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cerebrospinal fluid nitric oxide concentrations in degenerative cervical and lumbar diseases.
    Denda H; Kimura S; Yamazaki A; Hosaka N; Takano Y; Imura K; Yajiri Y; Endo N
    Eur Spine J; 2011 Apr; 20(4):604-11. PubMed ID: 21190044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cartilage-derived retinoic acid-sensitive protein in cerebrospinal fluid From patients With spinal diseases.
    Natsume N; Kondo S; Matsuyama Y; Sumida K; Inou H; Kawakami N; Sandell LJ; Iwata H
    Spine (Phila Pa 1976); 2001 Jan; 26(2):157-60. PubMed ID: 11154535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of low back pain using the Japanese Orthopaedic Association Back Pain Evaluation Questionnaire for lumbar spinal disease in a multicenter study: differences in scores based on age, sex, and type of disease.
    Ohtori S; Ito T; Yamashita M; Murata Y; Morinaga T; Hirayama J; Kinoshita T; Ataka H; Koshi T; Sekikawa T; Miyagi M; Tanno T; Suzuki M; Aoki Y; Aihara T; Nakamura S; Yamaguchi K; Tauchi T; Hatakeyama K; Takata K; Sameda H; Ozawa T; Hanaoka E; Suzuki H; Akazawa T; Suseki K; Arai H; Kurokawa M; Eguchi Y; Suzuki M; Okamoto Y; Miyagi J; Yamagata M; Toyone T; Takahashi K;
    J Orthop Sci; 2010 Jan; 15(1):86-91. PubMed ID: 20151256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of chondrex (YKL-40, HC gp-39) in the cerebrospinal fluid of patients with spine disease.
    Tsuji T; Matsuyama Y; Natsume N; Hasegawa Y; Kondo S; Kawakami H; Yoshihara H; Iwata H
    Spine (Phila Pa 1976); 2002 Apr; 27(7):732-5. PubMed ID: 11923666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide regulation system in degenerative lumbar disease.
    Watanabe T; Kato S; Sato K; Nagata K
    Kurume Med J; 2005; 52(1-2):39-47. PubMed ID: 16119611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of nitric oxide metabolites in spinal cord injury.
    Kimura S; Hosaka N; Yuge I; Yamazaki A; Suda K; Taneichi H; Denda H; Endo N
    Spine (Phila Pa 1976); 2009 Aug; 34(18):E645-52. PubMed ID: 19680090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental durotomy during lumbar spine surgery: risk factors and anatomic locations: clinical article.
    Takahashi Y; Sato T; Hyodo H; Kawamata T; Takahashi E; Miyatake N; Tokunaga M
    J Neurosurg Spine; 2013 Feb; 18(2):165-9. PubMed ID: 23199434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury.
    Hosaka N; Kimura S; Yamazaki A; Wang X; Denda H; Ito T; Hirano T; Endo N
    Eur Spine J; 2008 Feb; 17(2):281-6. PubMed ID: 17712576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain relief in degenerative lumbar diseases.
    Kimura S; Watanabe K; Yajiri Y; Uchiyama S; Hasegawa K; Shibuki K; Endo N
    Pain; 2001 Jun; 92(3):363-371. PubMed ID: 11376909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthroplasty for cervical spondylotic myelopathy: similar results to patients with only radiculopathy at 3 years' follow-up.
    Fay LY; Huang WC; Wu JC; Chang HK; Tsai TY; Ko CC; Tu TH; Wu CL; Cheng H
    J Neurosurg Spine; 2014 Sep; 21(3):400-10. PubMed ID: 24926929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminectomy and posterior cervical plating for multilevel cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome.
    Houten JK; Cooper PR
    Neurosurgery; 2003 May; 52(5):1081-7; discussion 1087-8. PubMed ID: 12699550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis.
    Asahara H; Yokoi I; Tamada T; Kabuto H; Ogawab N; Mori A; Inoue H
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):77-83. PubMed ID: 8824933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjacent segment degeneration after lumbosacral fusion in spondylolisthesis: a retrospective radiological and clinical analysis].
    Zencica P; Chaloupka R; Hladíková J; Krbec M
    Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):124-30. PubMed ID: 20447355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of spinal pathology in patients presenting for lumbar MRI as referred from general practice.
    de Schepper EI; Koes BW; Veldhuizen EF; Oei EH; Bierma-Zeinstra SM; Luijsterburg PA
    Fam Pract; 2016 Feb; 33(1):51-6. PubMed ID: 26659653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative retrolisthesis as a risk factor of postdecompression lumbar disc herniation.
    Takenaka S; Tateishi K; Hosono N; Mukai Y; Fuji T
    J Neurosurg Spine; 2016 Apr; 24(4):592-601. PubMed ID: 26654340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical stimulation threshold in chronically compressed lumbar nerve roots: Observational study.
    Plata-Bello J; Pérez-Lorensu PJ; Brage L; Hernández-Hernández V; Dóniz A; Roldán-Delgado H; Febles P; García-Conde M; Pérez-Orribo L; García-Marín V
    Clin Neurol Neurosurg; 2015 Dec; 139():1-5. PubMed ID: 26342804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide as an activity marker in multiple sclerosis.
    Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
    J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of Cervical Spondylotic Spinal Cord Compression on Cerebral Cortical Adaptation. Radiological Study].
    Hrabálek L; Hluštík P; Hok P; Čecháková E; Wanek T; Otruba P; Vaverka M; Kaňovský P
    Acta Chir Orthop Traumatol Cech; 2015; 82(6):404-11. PubMed ID: 26787180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.